TMEM63A

TMEM63A is a mechanically activated, non-selective cation channel that converts membrane tension into Ca2+ and monovalent cation flux to support tissue-specific mechanotransduction (PMID:31587869, PMID:38189136). It mediates pressure-dependent, voltage-independent currents with slow activation, no inactivation, sensitivity to Gd3+, and a high pressure threshold, and sustains stretch-evoked intracellular Ca2+ increases (PMID:38189136); cryo-EM resolves it as a monomeric protein with eleven transmembrane helices harboring the ion permeation pathway, architecturally distinct from the homodimeric plant OSCA channels (PMID:38217391). The protein localizes to plasma membrane, endoplasmic reticulum, and lysosomal membranes (PMID:35920704, PMID:40694323). At the lysosome it conducts cations out of the lumen to relieve hydrostatic pressure and membrane tension, conferring mechano-resilience against tension-induced lysis (PMID:41811130). Through this channel activity TMEM63A drives oligodendrocyte precursor differentiation and myelination via cell-autonomous Ca2+ influx (PMID:39982638, PMID:40694323), facilitates stretch-triggered surfactant and ATP release from lamellar bodies of alveolar type 2 cells (PMID:38127458), and mediates mechanical nociception in dorsal root ganglion nociceptors with downstream macrophage crosstalk in chronic pain (PMID:35821338). Heterozygous missense variants in the pore domain attenuate stretch-activated currents (PMID:31587869) and disease-associated variants block trafficking to the plasma membrane, causing hypomyelinating leukodystrophy (HLD19) (PMID:40694323).

1. 2016 Medium

   Established the first functional link between the TMEM63 family and osmosensitive ion conduction, raising the possibility that TMEM63A participates in an osmo-/mechanosensitive channel.

   Evidence Heterologous co-expression of all three mouse TMEM63 members in HEK293 cells with patch-clamp under hypertonic stimulation

   PMID:27045885

   Open questions at the time

   • Required all three family members, leaving TMEM63A-specific contribution ambiguous
   • Single lab and single method
   • Did not establish mechanical (stretch) gating directly
2. 2019 High

   Defined TMEM63A itself as a mechanically activated channel and localized its activity to the pore domain by showing disease variants attenuate stretch-activated current.

   Evidence Patch-clamp stretch-activated current recording of disease-associated TMEM63A variants in naive cells

   PMID:31587869

   Open questions at the time

   • Did not resolve channel architecture or ion selectivity
   • Mechanism linking variant to disease tissue not yet defined
3. 2022 Medium

   Placed TMEM63A in a protein-stability circuit at ER/lysosomal membranes, connecting it to VCP/DERL1 and TOLLIP-mediated autophagic turnover.

   Evidence Reciprocal Co-IP, fractionation/co-localization, knockdown/overexpression, xenograft, and pharmacological VCP inhibition (CB-5083)

   PMID:35920704

   Open questions at the time

   • Single lab
   • Relationship between this stability circuit and channel gating function unclear
   • No structural basis for the interactions
4. 2022 Medium

   Demonstrated an in vivo sensory role for TMEM63A in mechanical (but not thermal) nociception and uncovered nociceptor-macrophage crosstalk in chronic pain.

   Evidence Tmem63a knockout mice with von Frey/heat/cold behavioral testing, histology, and macrophage ablation

   PMID:35821338

   Open questions at the time

   • Single lab
   • Molecular signal from nociceptor to macrophage not defined
   • Channel biophysics in DRG neurons not measured directly
5. 2024 High

   Resolved the channel architecture as a monomeric eleven-TM protein with a defined permeation pathway, distinguishing it from homodimeric plant OSCA orthologs.

   Evidence Single-particle cryo-EM of human TMEM63A in the presence of calcium

   PMID:38217391

   Open questions at the time

   • Captured in a single state, not an open/gated conformation
   • Functional role of observed lipid-like density unresolved
   • No variant structures to explain loss of function
6. 2024 High

   Quantified the biophysical signature of TMEM63A as a high-threshold, slowly gating, non-inactivating cation channel that sustains stretch-evoked Ca2+ rise.

   Evidence High-speed pressure-clamp patch-clamp in Piezo1-KO HEK293T cells plus GCaMP5 Ca2+ imaging under whole-cell stretch

   PMID:38189136

   Open questions at the time

   • Single lab
   • Ion selectivity not fully dissected
   • Native gating tension in physiological membranes unknown
7. 2024 High

   Identified a physiological function in the lung: TMEM63A localizes to lamellar body membranes and couples stretch to surfactant/ATP release driving Ca2+-amplified exocytosis.

   Evidence TMEM63A/B double-knockout mice, localization imaging, cell-stretch assays, ATP/surfactant secretion and Ca2+ measurements

   PMID:38127458

   Open questions at the time

   • Redundancy with TMEM63B not separated for TMEM63A alone
   • Direct conduction at the lamellar body membrane not recorded
8. 2025 High

   Established the cell-autonomous requirement for TMEM63A-mediated Ca2+ influx in oligodendrocyte precursor differentiation and myelination, with variant-specific rescue.

   Evidence Tmem63a knockout mice, primary OPC differentiation and Ca2+ influx assays, lentiviral rescue with WT vs. A632T variant

   PMID:39982638

   Open questions at the time

   • Transient hypomyelination resolving by P28 leaves compensatory mechanism undefined
   • Downstream Ca2+-dependent differentiation effectors not identified
9. 2025 High

   Linked HLD19 pathogenesis to defective trafficking, showing patient variants fail to reach the plasma membrane, and confirmed cell-autonomous oligodendrocyte function by conditional knockout.

   Evidence OL-specific conditional Tmem63a knockout in mouse and zebrafish, localization imaging, and trafficking assays of disease variants

   PMID:40694323

   Open questions at the time

   • Whether trafficking loss versus pore loss dominates across all variants not delineated
   • Mechanism retaining variants intracellularly unknown
10. 2026 High

    Defined a lysosomal role: tension-gated cation efflux relieves luminal pressure and confers ~10-fold mechano-resilience against lysis.

    Evidence TMEM63A deletion and disease-variant expression with lysosomal lysis assays and osmotic/mechanical perturbation

    PMID:41811130

    Open questions at the time

    • Single lab
    • In vivo relevance of lysosomal mechano-resilience to disease not established
    • Coupling between lysosomal and plasma-membrane pools unclear
11. 2025 Medium

    Proposed an additional mechanically activated lipid scramblase activity through the same pore, regulated by cholesterol, expanding the protein's role to membrane remodeling.

    Evidence In vitro lipid scramblase and cellular translocation assays, groove-lining mutagenesis, MD simulations, cholesterol manipulation (preprint)

    PMID:bio_10.1101_2025.07.26.664997

    Open questions at the time

    • Preprint, not yet peer-reviewed
    • Single lab
    • Physiological contribution of scrambling relative to ion conduction unquantified in vivo

• How TMEM63A's channel, scramblase, and trafficking/stability functions are integrated across its plasma membrane, ER, and lysosomal pools to produce tissue-specific mechanotransduction remains unresolved.
• No open-state structure linking gating to permeation
• Native gating tension thresholds in each tissue undefined
• Relative contributions of ion flux versus lipid scrambling in vivo unknown